BIVDA Press Releases

23Feb

Member Press Release - BIVDA Member Randox Processes 10 Millionth COVID-19 Test

RANDOX PROCESSES ITS 10 MILLIONTH COVID-19 TEST AND DETAILS INVESTMENT IN TESTING CAPACITY

 

Randox Laboratories has confirmed that it has processed its 10 millionth sample for the UK’s COVID-19 National Testing Programme, making it the first Pillar 2 testing laboratory to achieve this milestone.  This achievement is based upon a £85 million investment since March 2020 in facilities and equipment at Randox’s laboratories in Northern Ireland.

 

As a key partner laboratory from initiation of the UK’s National Testing Programme in March 2020, Randox quickly ramped up its testing capacity.  Randox’s response has involved recruitment of over 850 new staff , the building and equipping of over 80,000 sq ft of new molecular laboratory space and the development of new innovations in testing technology. These efforts have seen Randox’s COVID-19 testing capacity grow from 150 tests per day in March 2020 to over 120,000 samples per day today, making Randox the largest throughput laboratory in the UK and Ireland and amongst the biggest in Europe.

 

Randox Founder and Managing Director, Dr Peter FitzGerald, said: This milestone is an incredible achievement and testament to the dedication and hard work of our teams, who have pulled together at a time of national crisis and whose non-stop efforts are vital to enable the country to return to both social and economic normality.

 

“We will continue to build our capacity and develop new cutting-edge testing equipment to support the fight against COVID-19.   We’ve all learnt from this pandemic the importance of early and accurate testing and Randox is committed to investing in diagnostic technology to meet future health challenges.”

 

  • ENDS -

 

Notes to editors

Randox is an international medical diagnostics company based in Antrim, Northern Ireland. Since its establishment in 1982, Randox has become a prominent world-leader in medical diagnostics and associated research and development, transforming the way patients are diagnosed and treated in over 145 countries. Randox is a premium provider of comprehensive health check services designed to empower its customers to take control of their health.

 

 

 

Related

BIVDA's response to the 2019 General Election result

Commenting on the result of the General Election, BIVDA’s Chief Executive Doris-Ann Williams MBE sa...

Read More >

BIVDA comments on Parliament’s vote on the EU withdrawal agreement

Doris-Ann Williams, Chief Executive of BIVDA, comments on today's vote

Read More >

Member Press Release - Stream Bio collaborates with MIP Diagnostics Ltd. on a rapid diagnostic and mass screening test for COVID-19

PRESS RELEASE22nd April 2020Stream Bio, a company that develops and manufactures a range of transfor...

Read More >

NHS could save nearly £7 billion through quick adoption of new diagnostic techniques

London, UK – Research commissioned by Innovate UK and the British In Vitro Diagnostics Association ...

Read More >

Member Press Release - Revolutionise Your Pancreatic Elastase Testing with Alpha Labs

Revolutionise Your Pancreatic Elastase Testing with the New BÜHLMANN fPELA® turboFaecal pan...

Read More >

BIVDA response to Parliament’s vote on the Brexit deal

Doris-Ann Williams, Chief Executive of BIVDA, comments on tonight's vote

Read More >